MF
VKTX icon

Magnetar Financial’s Viking Therapeutics VKTX Stock Holding History

Magnetar Financial’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
+11,368
New +$367K ﹤0.01% 649
2026
Q1 		– Sell
-15,647
Closed -$550K – 1417
2025
Q4 		$550K Buy
+15,647
New +$554K 0.01% 540
2025
Q3 		– Sell
-13,383
Closed -$355K – 1208
2025
Q2 		$355K Buy
13,383
+3,696
+38% +$97.3K ﹤0.01% 647
2025
Q1 		$234K Sell
9,687
-38,415
-80% -$1.21M ﹤0.01% 632
2024
Q4 		$1.94M Buy
+48,102
New +$2.74M 0.04% 225
2023
Q2 		– Sell
-14,250
Closed -$237K – 626
2023
Q1 		$237K Buy
+14,250
New +$147K ﹤0.01% 535

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Magnetar Financial's VKTX Position: Q2 2026 in Review

Magnetar Financial opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 11,368 shares worth $443K. The stake represents ﹤0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in VKTX as recently as Q4 2025.

Magnetar Financial first reported a position in VKTX in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.94M in Q4 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Magnetar Financial held 11,368 shares of Viking Therapeutics worth $443K as of Q2 2026.
  • Viking Therapeutics was a new Magnetar Financial position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #649 holding.
  • Magnetar Financial first reported a position in Viking Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • Magnetar Financial's Viking Therapeutics position peaked at $1.94M in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.